Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Pursuant to Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rekvina Laboratories has informed BSE that its Board of Directors will meet on Friday, 14 November 2025, to consider and approve the unaudited standalone financial results (under Ind AS) for the quarter and half year ended 30 September 2025. The company has also closed its trading window for designated persons from 1 October 2025 until 48 hours after the results are made public. No financial numbers or business updates have been disclosed in this filing — it is purely a procedural intimation ahead of the results announcement.
This is a routine regulatory filing with no immediate effect on shareholders or the stock price. Investors should watch the actual results announcement on or after 14 November 2025 for any meaningful financial signals.